Core Insights - Ekso Bionics has successfully demonstrated a proof-of-concept for integrating AI capabilities into its exoskeleton devices, specifically targeting both medical and industrial applications [1][3] - The new AI voice agent, named "Ekso Voice Agent," is designed for intelligent control of the legacy EksoNR device and operates on NVIDIA Jetson Orin Nano hardware [2][3] - The company has a substantial data repository with approximately 350,000 patient sessions and over 15 million data points, which is increasing by an average of 60,000 patient steps daily, positioning it well to leverage AI in exoskeleton technology [3] Company Overview - Ekso Bionics is a leading developer of exoskeleton solutions aimed at enhancing human strength, endurance, and mobility across various applications [5] - The company focuses on improving health and quality of life through advanced robotics, catering to individuals with paralysis and enhancing capabilities in industrial settings [5] - Ekso Bionics is headquartered in the San Francisco Bay Area and is publicly traded on the Nasdaq under the symbol "EKSO" [5] NVIDIA Connect Program - The company has been accepted into the NVIDIA Connect Program, which aims to accelerate product development and enhance cost efficiency for technology companies [4] - Members of this program receive specialized training, priority engineering support, and access to NVIDIA's advanced development kits and GPU platforms [4]

A video of the Ekso Voice Agent demonstration can be accessed here. About NVIDIA Connect NVIDIA Connect is a selective program that brings together emerging and established technology companies to accelerate product development and increase cost efficiency. Members gain specialized training, priority engineering support, and exclusive access to NVIDIA's advanced development kits, GPU platforms, and global ecosystem, helping them deliver next-generation solutions in AI and high-performance computing. AI voic ...